Hypoxic adaptation and the lungs: Levashov’s 2012 chapter. Ventilation, bronchial resistance, and multifactorial climate therapy.
Editor’s note. This is a book chapter, rather than a new single randomized protocol. The climate chamber described is not equivalent to modern short IHHT procedures. Below is a detailed English editorial exposition of the publication, rather than a complete verbatim translation. Complete methodological details, tables, illustrations, and references are available in the unchanged source PDF. This material does not provide separate clinical confirmation of OXYTERRA RS efficacy and is not treatment guidance.
Publication at a glance
- The chapter combines the method’s history with the author’s own observational series.
- Oxygen, humidity, temperature, and ionization were changed simultaneously in the climate chamber.
- The results do not isolate the effect of a hypoxic stimulus alone.
Hypoxic adaptation and the lungs
Historical and clinical context
Mikhail Levashov considers normobaric hypoxic adaptation in chronic lung diseases. The chapter begins with the history of mountain climate therapy, pressure chambers, and devices for generating hypoxic mixtures, before turning to observations of respiratory function.
Mountain climate combines several factors, rather than reduced oxygen alone. Moving to the mountains, a hypobaric chamber, and a normobaric gas environment differ physiologically. The author discusses these differences and the development of technical approaches.
What observations are presented
The author’s own series describe 36 healthy people, 103 people at high risk of COPD, and 157 patients with bronchial asthma, aged 21–59 years. These groups cannot automatically be combined into one randomized trial with a single control.
Exposure took place in an ‘Orotron’ climate chamber for two to four weeks, an hour and a half daily, either alone or alongside conventional therapy. In addition to the gas environment, specified humidity, temperature, and negative ion levels were maintained. The published partial-pressure notation contains ambiguous units, so it is not converted here into an oxygen prescription.
What was assessed
Ventilatory reserves, air distribution in the lungs, bronchial resistance, and respiratory cycle structure were studied. The author reports restoration of physiological alveolar ventilation in 78% of examined patients with COPD, a 25–30% reduction in ventilation unevenness, and a 31–37% reduction in airway resistance in patients with asthma.
These figures belong to the series described and the selected functional measures. They do not indicate the same percentage of asthma cures or prevented exacerbations. Similar physiological changes may have different clinical significance depending on disease severity and concomitant treatment.
What cannot be separated from the overall intervention
The climate chamber combines several exposures. With this arrangement, all changes cannot confidently be attributed to reduced oxygen alone. Comparable control conditions, a description of selection, and long-term follow-up of clinical outcomes are needed.
The author himself notes that outcomes depend on disease duration and severity, comorbidities, and steroid dependence. The approach is considered an adjunct to conventional care, rather than a replacement.
Editorial clarification: the chapter reflects research concepts from 2012. It does not justify unsupervised hypoxic exposure in lung disease, withdrawal of inhaled therapy, or extrapolation of climate-chamber results to OXYTERRA RS.
Original publication data
Complete source data are available in the attached file. The links below open the indicated PDF pages.
Patients and climate-chamber parameters
Technology and practice
How does the device-based procedure work? Read more about IHHT regimens and biofeedback.
The topic of IHHT in clinical practice and recovery is discussed in the Applications section.